AN2 Therapeutics, Inc.
US ˙ NasdaqGS ˙ US0373261058

Introduction

This page provides a comprehensive analysis of the known insider trading history of Tomas Jose D.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Tomas Jose D. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:DRVN / Driven Brands Holdings Inc. Director 27,478
US:ANTM / Anthem Inc EVP & Chief HR Officer 23,927
US:BKW / Burger King Worldwide Inc. Pres. LAC & Chief People Ofcr 27,397
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Tomas Jose D.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ANTX / AN2 Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ANTX / AN2 Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ANTX / AN2 Therapeutics, Inc. Insider Trades
Insider Sales ANTX / AN2 Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ANTX / AN2 Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ANTX / AN2 Therapeutics, Inc. Insider Trades
Insider Purchases DRVN / Driven Brands Holdings Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ANTX / AN2 Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DRVN / Driven Brands Holdings Inc. Insider Trades
Insider Sales DRVN / Driven Brands Holdings Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ANTX / AN2 Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DRVN / Driven Brands Holdings Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Tomas Jose D. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-03-17 2025-03-13 4 DRVN Driven Brands Holdings Inc.
Common Stock
A - Award 8,809 27,478 47.19
2024-02-29 2024-02-27 4 DRVN Driven Brands Holdings Inc.
Common Stock
A - Award 10,614 18,669 131.77
2023-03-02 2023-02-28 4 DRVN Driven Brands Holdings Inc.
Common Stock
A - Award 5,082 8,894 133.32
2022-08-05 2022-08-03 4 DRVN Driven Brands Holdings Inc.
Common Stock
A - Award 3,812 3,812
2017-03-07 2017-03-03 4 ANTM Anthem, Inc.
Common Stock
F - Taxes -2,615 23,927 -9.85 166.00 -434,090 3,971,880
2017-03-03 2017-03-02 4 ANTM Anthem, Inc.
Common Stock
F - Taxes -349 26,542 -1.30 165.97 -57,924 4,405,173
2017-03-03 2017-03-01 4 ANTM Anthem, Inc.
Employee Stock Option (Right to Buy)
A - Award 13,782 13,782
2017-03-03 2017-03-01 4 ANTM Anthem, Inc.
Common Stock
A - Award 3,369 26,891 14.32
2017-03-03 2017-03-01 4 ANTM Anthem, Inc.
Common Stock
F - Taxes -391 23,522 -1.64 166.97 -65,285 3,927,466
2017-01-10 2017-01-09 4 ANTM Anthem, Inc.
Common Stock
S - Sale X -6,500 23,913 -21.37 142.92 -928,980 3,417,644
2016-12-06 2016-12-02 4 ANTM Anthem, Inc.
Common Stock
F - Taxes -1,043 30,413 -3.32 145.10 -151,339 4,412,924
2016-03-04 2016-03-03 4 ANTM Anthem, Inc.
Common Stock
F - Taxes -2,176 31,161 -6.53 132.97 -289,343 4,143,420
2016-03-03 2016-03-02 4 ANTM Anthem, Inc.
Common Stock
F - Taxes -353 33,337 -1.05 134.09 -47,334 4,470,100
2016-03-03 2016-03-01 4 ANTM Anthem, Inc.
Employee Stock Option (Right to Buy)
A - Award 18,261 18,261
2016-03-03 2016-03-01 4 ANTM Anthem, Inc.
Common Stock
A - Award 4,268 33,690 14.51
2015-12-04 2015-12-02 4 ANTM Anthem, Inc.
Common Stock
F - Taxes -1,057 29,397 -3.47 132.92 -140,496 3,907,473
2015-03-04 2015-03-03 4 ANTM Anthem, Inc.
Common Stock
F - Taxes -2,338 30,323 -7.16 145.99 -341,325 4,426,877
2015-03-04 2015-03-03 4 ANTM Anthem, Inc.
Common Stock
A - Award 16,436 32,661 101.30
2015-03-04 2015-03-02 4 ANTM Anthem, Inc.
Employee Stock Option (Right to Buy)
A - Award 16,762 16,762
2015-03-04 2015-03-02 4 ANTM Anthem, Inc.
Common Stock
A - Award 3,829 16,225 30.89
2014-12-03 2014-12-02 4 ANTM Anthem, Inc.
Common Stock
F - Taxes -721 12,375 -5.51 128.71 -92,800 1,592,772
2014-03-05 2014-03-03 4 WLP WELLPOINT, INC
Stock Option (Right to Buy)
A - Award 22,817 22,817
2014-03-05 2014-03-03 4 WLP WELLPOINT, INC
Common Stock
A - Award 5,591 13,045 75.01
2013-12-04 2013-12-02 4 WLP WELLPOINT, INC
Employee Stock Option (Right to Buy)
A - Award 9,180 9,180
2013-12-04 2013-12-02 4 WLP WELLPOINT, INC
Common Stock
A - Award 7,454 7,454
2013-12-04 3 WLP WELLPOINT, INC
Common Stock
0
2013-03-05 2013-03-01 4 BKW Burger King Worldwide, Inc.
Option (Right to Buy)
J - Other 27,397 27,397
2013-03-05 2013-03-01 4 BKW Burger King Worldwide, Inc.
Common Stock
J - Other 8,219 65,850 14.26 18.25 149,997 1,201,762
2012-06-21 2012-06-20 4 BKW Burger King Worldwide, Inc.
Option (right to buy)
A - Award 174,969 174,969
2012-06-21 2012-06-20 4 BKW Burger King Worldwide, Inc.
Option (right to buy)
A - Award 466,629 466,629
2012-06-21 2012-06-20 4 BKW Burger King Worldwide, Inc.
Common Stock
A - Award 57,631 57,631
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)